Subpopulations in aMPV vaccines are unlikely to be the only cause of reversion to virulence
Highlights • Development of different NGS protocols for aMPV full genome sequencing. • First study investigating aMPV vaccine subpopulation using NGS. • Comparison of identified SNV with attenuation/reversion to virulence markers. • Evidence of the role of intra-vaccine variability in vaccine revers...
Gespeichert in:
Veröffentlicht in: | Vaccine 2015-05, Vol.33 (21), p.2438-2441 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • Development of different NGS protocols for aMPV full genome sequencing. • First study investigating aMPV vaccine subpopulation using NGS. • Comparison of identified SNV with attenuation/reversion to virulence markers. • Evidence of the role of intra-vaccine variability in vaccine reversion to virulence. |
---|---|
ISSN: | 0264-410X 1873-2518 0264-410X |
DOI: | 10.1016/j.vaccine.2015.03.092 |